Prelude Therapeutics (PRLD) Institutional Ownership $0.96 -0.08 (-7.68%) Closing price 04:00 PM EasternExtended Trading$0.97 +0.01 (+0.61%) As of 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Prelude Therapeutics (NASDAQ:PRLD)CurrentInstitutional OwnershipPercentage79.72%Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$5.87MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$491.84K Get PRLD Insider Trade Alerts Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PRLD Institutional Buying and Selling by Quarter Prelude Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025 Acadian Asset Management LLC529,327$405K0.0%+9.1%0.938% 5/16/2025 AQR Capital Management LLC33,823$26K0.0%+170.7%0.078% 5/12/2025 Simplex Trading LLC41,846$32K0.0%+121.2%0.096% 5/9/2025 Deutsche Bank AG80,723$62K0.0%-34.8%0.185% 2/17/2025 Two Sigma Investments LP231,839$296K0.0%+307.2%0.421% 2/17/2025 Two Sigma Advisers LP300,000$382K0.0%+526.3%0.545% 2/17/2025 Millennium Management LLC462,555$590K0.0%+188.2%0.841% 2/17/2025 Jacobs Levy Equity Management Inc.666,574$850K0.0%+280.9%1.211% 2/17/2025 Deutsche Bank AG123,899$159K0.0%+747.6%0.225% 2/17/2025 Bridgeway Capital Management LLC111,000$142K0.0%-37.0%0.202% Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 BNP Paribas Financial Markets20,572$26K0.0%N/A0.037% 2/14/2025 Boxer Capital Management LLC1,708,187$2.18M0.2%N/A3.104% 2/14/2025 Northern Trust Corp83,387$106K0.0%-21.6%0.152% 2/14/2025 Price T Rowe Associates Inc. MD1,029,199$1.31M0.0%-6.2%1.870% 2/13/2025 Marshall Wace LLP392,155$498K0.0%+9.2%0.713% 2/13/2025 Renaissance Technologies LLC634,500$809K0.0%+222.2%1.153% 2/12/2025 Massachusetts Financial Services Co. MA494,497$630K0.0%-10.0%0.899% 2/12/2025 JPMorgan Chase & Co.61,149$78K0.0%+925.0%0.111% 2/6/2025 Charles Schwab Investment Management Inc.117,200$149K0.0%-12.0%0.213% 1/30/2025 Rhumbline Advisers166,830$213K0.0%+1,289.8%0.303% 11/19/2024 Barclays PLC27,165$57K0.0%+86.0%0.049% 11/16/2024 Geode Capital Management LLC391,716$811K0.0%+8.2%0.712% 11/15/2024 Barclays PLC27,165$57K0.0%+86.0%0.049% 11/15/2024 XTX Topco Ltd48,239$100K0.0%N/A0.088% 11/15/2024 State Street Corp286,046$592K0.0%+35.1%0.520% 11/15/2024 Jacobs Levy Equity Management Inc.174,979$362K0.0%+885.2%0.318% 11/14/2024 Walleye Capital LLC83,175$172K0.0%+446.2%0.151% 11/12/2024 Massachusetts Financial Services Co. MA549,530$1.14M0.0%+5.2%0.999% 10/10/2024 Exchange Traded Concepts LLC64,409$133K0.0%+32.2%0.153% 8/15/2024 The Manufacturers Life Insurance Company70,045$267K0.0%-3.1%0.166% 8/9/2024 Renaissance Technologies LLC206,600$787K0.0%-15.6%0.491% 8/9/2024 Dimensional Fund Advisors LP29,074$111K0.0%+103.2%0.069% 8/9/2024 Massachusetts Financial Services Co. MA522,375$1.99M0.0%+2.8%1.241% 7/26/2024 Bank of New York Mellon Corp36,276$138K0.0%-9.5%0.086% 5/16/2024 Kennedy Capital Management LLC25,035$119K0.0%N/A0.059% 5/15/2024 Price T Rowe Associates Inc. MD941,971$4.47M0.0%-9.7%2.239% 5/10/2024 Acadian Asset Management LLC22,110$104K0.0%+42.7%0.053% 5/10/2024 Vanguard Group Inc.1,016,999$4.82M0.0%+1.0%2.417% 2/15/2024Boxer Capital LLC2,568,287$10.97M0.5%+2.9%4.684% 2/14/2024 Pale Fire Capital SE63,581$271K0.0%+106.6%0.116% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more.1/12/2024 SG Americas Securities LLC13,100$56K0.0%N/A0.024% 1/5/2024 Exchange Traded Concepts LLC44,087$188K0.0%+34.0%0.080% 11/14/2023 Pale Fire Capital SE30,781$95K0.0%N/A0.056% 11/13/2023 FMR LLC5,131,433$15.86M0.0%-13.6%9.359% 11/7/2023 Barclays PLC13,316$42K0.0%+120.0%0.024% 10/27/2023 TD Asset Management Inc160,652$496K0.0%+100.0%0.293% 10/18/2023 Exchange Traded Concepts LLC32,907$102K0.0%+29.4%0.060% 9/21/2023 Barclays PLC6,052$27K0.0%-41.4%0.011% 8/15/2023Boxer Capital LLC2,495,018$11.23M0.5%+256.9%4.552% 8/9/2023 TD Asset Management Inc80,326$361K0.0%+182.4%0.147% 7/20/2023 Exchange Traded Concepts LLC25,428$114K0.0%N/A0.053% 5/16/2023Boxer Capital LLC699,047$3.99M0.2%N/A1.458% 5/1/2023 Virtu Financial LLC11,201$64K0.0%N/A0.023% 2/14/2023 683 Capital Management LLC28,631$173K0.0%N/A0.060% 2/13/2023 GSA Capital Partners LLP47,801$289K0.0%-11.8%0.100% 2/10/2023 New York Life Investment Management LLC82,000$495K0.0%+11.7%0.171% 2/9/2023 Citigroup Inc.60,072$363K0.0%+604.1%0.126% 2/7/2023 Bleakley Financial Group LLC22,325$135K0.0%N/A0.047% 11/15/2022Caxton Associates LP85,992$568K0.1%+2.5%0.180% 11/14/2022 PDT Partners LLC12,641$84K0.0%-71.1%0.026% 11/9/2022 Massachusetts Financial Services Co. MA513,293$3.39M0.0%+7.3%1.073% 10/25/2022 Denali Advisors LLC8,200$54K0.0%N/A0.017% 8/16/2022 Corton Capital Inc.15,586$81K0.1%+42.8%0.033% 8/16/2022Delphia USA Inc.16,940$88K0.1%N/A0.035% 8/13/2022 Massachusetts Financial Services Co. MA478,525$2.50M0.0%-0.7%1.000% 8/12/2022 Virtus ETF Advisers LLC24,005$125K0.0%+84.0%0.050% 7/19/2022 Commonwealth Equity Services LLC16,617$86K0.0%-18.8%0.035% 5/11/2022 Massachusetts Financial Services Co. MA482,119$3.33M0.0%+2.8%1.012% 5/11/2022 GSA Capital Partners LLP23,201$160K0.0%N/A0.049% 5/6/2022IndexIQ Advisors LLC56,750$392K0.0%N/A0.119% 5/5/2022 New York State Common Retirement Fund4,992$34K0.0%-45.1%0.010% 5/4/2022 Commonwealth Equity Services LLC20,467$141K0.0%-10.4%0.043% 3/3/2022 Walleye Capital LLC41,954$522K0.0%N/A0.089% 2/14/2022 PDT Partners LLC35,907$447K0.0%N/A0.076% 2/14/2022 Virtus ETF Advisers LLC13,815$172K0.1%+119.6%0.029% 2/14/2022 Point72 Hong Kong Ltd3,872$48K0.0%+141.7%0.008% 2/11/2022 Ensign Peak Advisors Inc8,080$101K0.0%N/A0.017% 2/11/2022 Parkwood LLC12,667$158K0.0%N/A0.027% 2/10/2022 Qube Research & Technologies Ltd23,384$291K0.0%N/A0.050% 2/10/2022 Massachusetts Financial Services Co. MA468,797$5.84M0.0%-0.7%0.993% 2/8/2022 Swiss National Bank27,500$342K0.0%+34.1%0.058% 2/1/2022 Qube Research & Technologies Ltd23,384$291K0.0%N/A0.050% 1/31/2022 Commonwealth Equity Services LLC22,832$284K0.0%+69.4%0.048% 12/14/2021 UBS Asset Management Americas Inc.1,483,319$46.35M0.0%+15.2%3.142% 11/15/2021 Point72 Hong Kong Ltd1,602$50K0.0%N/A0.003% 11/15/2021 Cubist Systematic Strategies LLC21,755$680K0.0%+26.5%0.046% 11/15/2021 California State Teachers Retirement System13,524$423K0.0%-9.5%0.029% 11/15/2021 Rock Springs Capital Management LP362,359$11.32M0.2%-5.2%0.769% 11/15/2021 Morgan Stanley756,787$23.65M0.0%+472.6%1.607% 11/12/2021Credit Suisse AG6,950$216K0.0%N/A0.015% Gold is soaring. Here’s how to get paid from it (Ad)Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.Click here to discover the income ETF behind it all.11/12/2021 Geode Capital Management LLC249,172$7.79M0.0%+11.6%0.529% 11/10/2021 Goldman Sachs Group Inc.8,659$271K0.0%-53.5%0.018% 11/10/2021 Citigroup Inc.24,268$758K0.0%-67.9%0.052% 11/10/2021 Rafferty Asset Management LLC36,936$1.15M0.0%-25.8%0.078% 11/10/2021 Alliancebernstein L.P.13,700$428K0.0%-23.5%0.029% 11/10/2021 Massachusetts Financial Services Co. MA472,246$14.76M0.0%+25.9%1.003% 11/9/2021BlackRock Inc.725,962$22.69M0.0%+3.3%1.542% 11/4/2021 Deutsche Bank AG6,537$205K0.0%-82.4%0.014% 11/1/2021 SG Americas Securities LLC8,691$272K0.0%N/A0.018% 10/29/2021 Commonwealth Equity Services LLC13,482$421K0.0%+23.4%0.029% (Data available from 1/1/2016 forward) PRLD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PRLD shares? During the previous two years, 35 institutional investors and hedge funds held shares of Prelude Therapeutics. The most heavily invested institutionals were FMR LLC ($15.86M), Boxer Capital LLC ($10.97M), Vanguard Group Inc. ($4.82M), Boxer Capital Management LLC ($2.18M), Price T Rowe Associates Inc. MD ($1.31M), Jacobs Levy Equity Management Inc. ($850K), and Geode Capital Management LLC ($811K).Learn more on PRLD's institutional investors. What percentage of Prelude Therapeutics stock is owned by institutional investors? 79.72% of Prelude Therapeutics stock is owned by institutional investors. Learn more on PRLD's institutional investor holdings. Which institutional investors have been buying Prelude Therapeutics stock? Of the 28 institutional investors that purchased Prelude Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Boxer Capital LLC ($1.87M), Boxer Capital Management LLC ($1.71M), Jacobs Levy Equity Management Inc. ($648.81K), Renaissance Technologies LLC ($437.60K), Millennium Management LLC ($302.03K), Two Sigma Advisers LP ($252.10K), and Two Sigma Investments LP ($174.91K). How much institutional buying is happening at Prelude Therapeutics? Institutional investors have bought a total of 6,473,212 shares in the last 24 months. This purchase volume represents approximately $15.44M in transactions. Which Prelude Therapeutics major shareholders have been selling company stock? Of the 11 institutional investors that sold Prelude Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($808.79K), Price T Rowe Associates Inc. MD ($169.17K), Bridgeway Capital Management LLC ($65.10K), Massachusetts Financial Services Co. MA ($55.03K), Deutsche Bank AG ($43.18K), Renaissance Technologies LLC ($38.20K), and Northern Trust Corp ($22.99K). How much institutional selling is happening at Prelude Therapeutics? Institutional investors have sold a total of 1,228,780 shares in the last 24 months. This volume of shares sold represents approximately $3.49M in transactions. Related Companies enGene Major Shareholders scPharmaceuticals Major Shareholders CytomX Therapeutics Major Shareholders Bright Minds Biosciences Major Shareholders CARGO Therapeutics Major Shareholders Innate Pharma Major Shareholders Nanobiotix Major Shareholders Instil Bio Major Shareholders SOPHiA GENETICS Major Shareholders biote Major Shareholders This page (NASDAQ:PRLD) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
